Cite
Distinct Lipidomic Profiles between People Living with HIV Treated with E/C/F/TAF or B/F/TAF: An Open-Label Prospective Cohort Study.
MLA
Wan, Zhikai, et al. “Distinct Lipidomic Profiles between People Living with HIV Treated with E/C/F/TAF or B/F/TAF: An Open-Label Prospective Cohort Study.” Infectious Diseases & Therapy, vol. 13, no. 4, Apr. 2024, pp. 727–44. EBSCOhost, https://doi.org/10.1007/s40121-024-00943-0.
APA
Wan, Z., Su, J., Zhu, X., Liu, X., Guo, Y., Xiang, D., Zhou, X., Peng, X., Tao, R., Cao, Q., Lang, G., Huang, Y., & Zhu, B. (2024). Distinct Lipidomic Profiles between People Living with HIV Treated with E/C/F/TAF or B/F/TAF: An Open-Label Prospective Cohort Study. Infectious Diseases & Therapy, 13(4), 727–744. https://doi.org/10.1007/s40121-024-00943-0
Chicago
Wan, Zhikai, Junwei Su, Xueling Zhu, Xiang Liu, Yongzheng Guo, Dairong Xiang, Xiaotang Zhou, et al. 2024. “Distinct Lipidomic Profiles between People Living with HIV Treated with E/C/F/TAF or B/F/TAF: An Open-Label Prospective Cohort Study.” Infectious Diseases & Therapy 13 (4): 727–44. doi:10.1007/s40121-024-00943-0.